Guidelines

Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMT

Department of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, TN, USA
Department of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, TN, USA
Department of Haematology and EBMT Paris study office / CEREST-TC, Saint Antoine Hospital, Paris, France
Department of Oncology Hematologic Malignancies, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Department of Pediatric Hematology/Oncology and Cell and Gene Therapy, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy
Department of Laboratory Medicine, CAST, Karolinska Institutet and University Hospital, Stockholm, Sweden
Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA
Stem Cell Transplant and Cellular Therapy, Thammasat University, Pathumthani, Thailand
Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA
Peking University People’s Hospital, Peking University Institute of Hematology, Beijing China
Department of Pediatric Hematology/Oncology, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Sapienza, University of Rome, Italy
Department of Medicine and Surgery, University of Parma, Parma, Italy
Instituto Clinico Humanitas, Rozzano Milano, Italy
Fondazione Policlinico Universitario Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy
University of Perugia, Sant’Andrea Delle Fratte, Perugia Italy
Department of Hematology, Institut Paoli Calmettes, Marseille France
Department of Clinical Psychology, Paoli-Calmettes Institute, Marseille, France
Institut Paoli-Calmette, département de psychologie clinique, Marseille, France
Department of Hematology and Oncology, University Children’s Hospital Tübingen, Tübingen Germany
Division of Hematology and Medical Oncology, Hospital Maisonneuve-Rosemont, Montreal, QC, Canada
Hematology-Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
Blood and Marrow Transplant Program at Northside Hospital, Atlanta, GA, USA
Blood and Marrow Transplant Program at Northside Hospital, Atlanta, GA, USA
Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
Hematology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium
HGU Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain
Oncology and immunology, Dmitriy Rogachev National Medical Center of pediatric hematology, Moscow, Russia
Adult Hematologic Malignancies & Stem Cell Transplant Section, University Hospitals Seidman Cancer Center, Cleveland, OH, USA
Division of hematology/oncology, University of Virginia Health System, Charlottesville, VA, USA
Dept. of Bone Marrow Transplantation and Onco-Hematology, Maria Sklodowska-Curie Institute - Oncology Center, Gliwice Branch, Gliwice, Poland
Laboratory of Hematology, University of Liège, Liège, Belgium
Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milano Italy
Hematology department, Hospital Clínic de Barcelona, Barcelona Spain
Service d’hématologie et thérapie cellulaire Centre international greffes APHP-EBMT-INCa Hospital, Saint Antoine Hospital, Paris France
Bone Marrow Transplantation Unit and CBMDP Donor Center, University Hospital of Patras, Patras, Greece
Department of Hematology and Oncology, Klinikum Augsburg, Augsburg, Germany
Stem Cell Transplant and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Chaim Sheba Medical Center, Tel Aviv University, Tel-Hashomer, Israel and EBMT ALWP office, Saint Antoine Hospital, Paris, France
Service d’Hématologie Clinique et Thérapie Cellulaire, Hôpital Saint-Antoine, AP-HP, Sorobonne University, and INSERM UMRs 938, Paris, France
Vol. 105 No. 1 (2020): January, 2020 https://doi.org/10.3324/haematol.2019.219790